Mr. Bogner writes, “While the challenge of treating cardiovascular disease is daunting, I am optimistic about the progress we have made by developing a revolutionary MedTech device that will provide a solution for patients with privilege and without. I am looking forward to the next milestone of our first human use trials in Europe in early 2023.” Read more what he has to say.

The potential of voice biomarkers is advancing and opening new opportunities for diagnoses, risk prediction, clinical outcomes, and symptomology.  As one of the most promising digital healthcare sectors, all age cohorts, especially the aging population, may see the most benefit. Read what Mr. Tal has to say.

In the October 2022 issue of the International Journal of Spine Surgery, the International Society for the Advancement of Spine Surgery (ISASS) published an updated Policy Statement and Literature Review of Intraosseous Basivertebral Nerve Ablation. This revised statement followed the September 2022 publication of Best Practice Guidelines on the Diagnosis and Treatment of Vertebrogenic Low Back Pain with Basivertebral Nerve Ablation from the American Society of Pain and Neuroscience (ASPN).

Healthcare services have been buffeted on the rocks of the global pandemic since early 2020, and many are now trying to address the significant backlog in non-urgent and elective surgeries that have been postponed by primary healthcare focusing on COVID-19.
As we enter the post-pandemic era, Bernard Ross, CEO, and Founder of Sky Medical Technology outlines his views on the direction of travel of the healthcare industry in 2023 and the implications for MedTech.

Dr. David Z. Rose is a Vascular Stroke Neurologist at the University of South Florida College of Medicine in Tampa, Florida, USA, and Co-Medical Director of the 32-bed Neuro-ICU at Tampa General Hospital. He is the author of a fun review book entitled “Laughing Your Way to Passing the Neurology Boards” and many peer-reviewed articles on Neuro-Cardio topics. He completed an Internal Medicine internship and residency at the Cleveland Clinic in Ohio, Neurology residency at the University of Miami/Jackson.

Ann Demaree writes, “While OTC wearable devices are designed to allow for augmented individual monitoring of body parameters, identifying deviations that can empower people to make educated decisions on their personal fitness and health, the question is, just how accurate are they and where should they fit within the ideal healthcare ‘ecosystem’?”